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Abstract
Introduction: Stasilon® is a novel hemostatic woven textile composed of allergen-free fibers of continuous
filament fiberglass and bamboo yarn. The development of this product resulted from controlled in vitro
thrombogenic analysis of an array of potentially hemostatic textile materials and it has been cleared for both
external and internal use by the United States Food and Drug Administration for the arrest of hemorrhage. The
goal of the study was to assess the hemostatic and adhesive properties of Stasilon® in the setting of life-
threatening refractory hemorrhage.
Case presentation: A 39-year-old Caucasian man presented with severe necrotic pancreatitis that failed multiple
aggressive attempts to control associated bleeding with electrocautery, suture ligation, and sequential anatomic
packing with cotton-based sponges. Subsequent retroperitoneal packing with Stasilon® produced a non-adherent
wound-dressing interface and resulted in the achievement of persistent hemostasis in the operative field.
Conclusion: In our patient, Stasilon® was demonstrated to be effective in the arrest of refractory hemorrhage.
Introduction
Uncontrolled hemorrhage is a major contributor to both
trauma-associated and intra-operative morbidity and
mortality [1,2]. Achieving hemostasis is crucial in avoid-
ing distributive shock and interrupting the progressive
physiologic compromise that is often marked by dilu-
tional coagulopathy, metabolic acidemia, and the seque-
lae of microcirculatory malperfusion [3,4]. Cotton-fiber-
based dressings have traditionally been used liberally in
wound management, but the minimally thrombogenic
nature of their blood-matrix interface, the inherently
adhesive nature of their surfaces to the wound bed, and
their highly absorptive qualities make them less than
ideal dressings. Modern textile sciences have enabled
the development of novel hemostatic materials that have
been specifically engineered to incorporate many of the
most desirable qualities of the ideal dressing [5,6]. Stasi-
lon® is a novel hemostatic woven textile composed of
allergen-free fibers of continuous filament fiberglass and
bamboo yarn. The goal of this report is to document
our experience with the use of Stasilon® in a case of per-
sistent retroperitoneal hemorrhage that could not be
controlled by traditional means of securing hemostasis.
Case presentation
A 39-year-old Caucasian man presented to our emer-
gency department with a 1-day history of nausea, vomit-
ing, and severe peri-umbilical pain that radiated to the
mid-scapular region of his back. The patient had a his-
tory of muscular dystrophy, hypertension, and transient
renal insufficiency. There was no elicited history of
jaundice, cholelithiasis, or bleeding diathesis. The patient
used smokeless tobacco products and consumed three
or more alcoholic drinks per day. On admission, labora-
tory results revealed no leukocytosis, a normal serum
hemoglobin concentration, and normal renal function.
Serum lipase was elevated at 1985 U/l. Transaminases
and alkaline phosphate levels were mildly elevated;
serum bilirubin was normal. Abdominal ultrasonography
demonstrated edema of the pancreatic head without evi-
dence of cholelithiasis. Computed tomographic (CT)
imaging with intravenous and oral contrast confirmed
inhomogeneous pancreatic enhancement localized to the
* Correspondence: prich@med.unc.edu
Department of Surgery, Division of Trauma and Critical Care, University of
North Carolina, Chapel Hill, NC 27599-7228, USA
Rich et al. Journal of Medical Case Reports 2010, 4:20
http://www.jmedicalcasereports.com/content/4/1/20 JOURNAL OF MEDICAL
CASE REPORTS
© 2010 Rich et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.head and uncinate process without evidence of necrosis
or associated hemorrhage. The patient was maintained
nil by mouth and admitted to the hospital for intrave-
nous resuscitation and monitoring.
The patient developed multiple system organ dysfunc-
tion secondary to pancreatitis. On day 28, CT scanning
and percutaneous sampling confirmed infected pancrea-
tic necrosis (>50%).
The patient was taken to the operating room for
laparotomy and exploration of the retroperitoneum. Dif-
fuse fibrinous inflammation of the intra-abdominal con-
tents and omentum was identified as was extensive
retroperitoneal necrosis of the pancreas and surrounding
peri-pancreatic tissues. An 80% pancreatic necrosectomy
was performed which was accompanied by significant
retroperitoneal bleeding. Attempts at hemorrhage con-
trol with electrocautery and suture ligation were unsuc-
cessful. Associated hypotension required damage control
treatment [7]; the retroperitoneum was packed with cot-
ton sponges, the abdomen left open under sterile dres-
sings, and the patient was transferred to the intensive
care unit (ICU).
Progressive coagulopathy and hemodynamic compro-
mise necessitated continued transfusion of blood and
blood products and the intravenous administration of
activated Factor VII (VIIa). Several hours after ICU
admission, the abdomen was re-explored at the bedside
for unabated bleeding and continued hypotension,
despite correction of coagulopathy. Two liters of hemo-
peritoneum were evacuated and diffuse microvascular
bleeding was encountered in the retroperitoneum of the
left upper quadrant. Electrocautery and suture ligation
were ineffective and the abdomen was repacked with
cotton laparotomy pads and the abdomen left open.
Mesenteric angiography was performed after failure to
achieve operative hemostasis; this demonstrated splenic
arterial thrombosis without active arterial bleeding.
Hemodynamics briefly improved and the patient was
returned to the operating room for re-exploration and
pack removal. The cotton packs were noted to be den-
sely adherent to the retroperitoneum and diffuse re-
bleeding occurred after their removal. Cautery and
suture ligation again yielded incomplete hemostasis and
fresh packs were replaced. Following additional transfu-
sion and resuscitation in the ICU, the patient was
returned to the operating room for another attempt at
pack removal. Again, hemodynamically significant bleed-
ing occurred from the exposed retroperitoneum upon
pack removal. A splenectomy was performed to reduce
the potential for collateral bleeding in the setting of
proximal splenic arterial thrombosis but significant
bleeding continued from the pancreatic bed.
Two 4-inch by 48-inch rolls of woven Stasilon® textile
(Entegrion, Research Triangle Park, NC, USA) were
packed into the retroperitoneal space and pressure was
applied for 4 minutes (Figure 1). Hemostasis was
achieved with this maneuver, hemodynamics improved,
and the patient was returned to the ICU for continued
resuscitation with the new packs in place. Following the
Stasilon® packing, additional transfusions were not
required, and hemodynamics were maintained. Forty-
eight hours later, the patient was again returned to the
operating room for re-exploration. At laparotomy, the
packs were noted to be within a hemostatic field.
Although directly contiguous with exposed structures,
the Stasilon® dressings did not adhere to the retroperito-
neal tissues and the material was able to be removed
from the pancreatic bed atraumatically (Figure 2). Com-
plete hemostasis was noted in the retroperitoneum and
left upper quadrant; no further hemostatic maneuvers
were required (Figure 3). The region was widely drained
and the abdomen closed with Dexon™ mesh.
Postoperatively, adequate hemodynamics were
restored, resuscitation was successful, and vasopressor
infusions were discontinued. Despite the eventual
achievement of retroperitoneal hemostasis following the
necrosectomy, the patient’s subsequent hospital course
was marked by progressive multiple system organ dys-
function and numerous associated complications. Ulti-
mately, supportive interventions were ended and the
patient died approximately 4 weeks after the final lapar-
otomy that established retroperitoneal hemorrhage
control.
Discussion
The two component fibers used in the manufacture of
Stasilon® were selected from a panel of candidate mate-
rials based on their selective thrombogenicity as mea-
sured by acceleration of platelet-dependent turnover
within the coagulation cascade and subsequent genera-
tion of thrombin. The resultant textile is generated from
a proprietary weave of its two components, continuous
filament type E glass (65%) and regenerated bamboo
(35%). The weave pattern is unique and was engineered
to optimize the contact surface area between the textile
structure and blood components. The Stasilon® fabric
can be woven into widths of 1 to 4 inches from continu-
ous filament fiberglass and bamboo precursors but is
typically finished as a flat, 4-inch square (4 × 4 inches),
single-layer pad that is individually packaged, sealed,
depyrogenated, and sterilized with ethylene oxide gas.
The manufacturing process can be modified to allow for
variations in the dressing length and width including the
packaging of sterile rolls of the product.
The process of Stasilon® application is similar to that
of familiar cotton products: sterile dressings are
removed from the packaging, placed directly on the
wound surface, and pressure is applied. Pre-clinical
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advantages over more traditional dressings including the
induction of more rapid hemostasis, the corollary
absorption of less shed blood, and less associated wound
adherence resulting in more stable clot integrity proxi-
mate to the wound surface. Stasilon® has been cleared
by the United States Food and Drug Administration
(USFDA) for external and internal use and has been
granted over-the-counter status making it available
without a prescription. Although Stasilon® has been
cleared for up to 30 days of implantation, we recom-
mend its removal as soon as clinically feasible.
In this observational case study, we report the first intra-
operative use of Stasilon® as a hemostatic device to curtail
uncontrolled hemorrhage from a surgical wound bed. Our
patient suffered multiple episodes of life-threatening retro-
peritoneal exsanguination that were refractory to thera-
peutic interventions including liberal use of electrocautery
Figure 1 Stasilon®. Stasilon® is a novel textile dressing composed of fiberglass and bamboo yarns incorporated into a proprietary weave. It has
been cleared by the United States Food and Drug Administration for external and internal use and has been granted over-the-counter status.
Figure 2 Stasilon® was non-adherent to the wound bed. Forty-eight hours after open transabdominal packing, Stasilon® rolls were noted to
be non-adherent to the hemostatic wound bed and were easily removed atraumatically from the retroperitoneum.
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coagulopathy and thrombocytopenia, sequential attempts
at cotton-based packing, visceral angiography, and ulti-
mately splenectomy. A single application of Stasilon® pack-
ing in our patient resulted in complete resolution of
associated hemorrhage, the attainment of hemodynamic
stability with the ability to discontinue vasopressor sup-
port, and obviated the need for further perioperative trans-
fusion of blood and blood products.
On re-exploration for pack removal 48 hours after place-
ment, the Stasilon® rolls were noted to be in direct juxta-
position to the hemostatic retroperitoneal surfaces but
were not adherent to the surrounding tissue structures.
This property facilitated atraumatic removal of the dres-
sings and left behind stable thrombus on the wound bed.
Although the patient ultimately died from multiple system
organ dysfunction and complications resulting from severe
underlying disease pathophysiology, we believe that the
hemostatic properties and reduced tissue adhesion of the
novel textile Stasilon® directly contributed to the arrest of
the life-threatening retroperitoneal hemorrhage encoun-
tered early in the patient’s hospital course. Controlled stu-
dies of this novel dressing will facilitate objective analysis
of its effectiveness.
Conclusions
The use of Stasilon® textile dressings in this patient pro-
duced robust hemostasis without associated wound adher-
ence and resulted in the successful treatment of refractory
hemorrhage. This novel hemostatic textile offers potential
clinical advantages for the arrest of bleeding.
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Figure 3 After Stasilon® removal, the retroperitoneum remained dry. After pack removal, the retroperitoneum remained dry. The area was
widely drained and the abdomen was able to be closed with Dexon™ mesh without plans for subsequent laparotomy.
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